Vermillion Wealth Management, Inc.
Position in RXRX — Recursion Pharmaceuticals, Inc.
CIK 1737012
ROSEMOUNT, MN
Position in RXRX
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$513
+$84 QoQ
Shares Held
140
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#329
of 338 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Vermillion Wealth Management, Inc. holds $68,753 across 7 Biotechnology names. RXRX ranks #7 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TGTX |
Tg Therapeutics, Inc.
|
500 | $27,470 | |
| 2 | CAI |
Caris Life Sciences, Inc.
|
1,000 | $17,820 | |
| 3 | SMMT |
Summit Therapeutics Inc.
|
1,000 | $14,570 | |
| 4 | AVXL |
Anavex Life Sciences Corp.
|
2,000 | $5,180 | |
| 5 | CELC |
Celcuity Inc.
|
20 | $2,092 | |
| 6 | TNYA |
Tenaya Therapeutics, Inc.
|
1,500 | $1,108 | |
| 7 | RXRX |
Recursion Pharmaceuticals, Inc.
This page
|
140 | $513 |
All Filings in RXRX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $513 | 140 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $429 | 140 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $572 | 140 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $683 | 140 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $708 | 140 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $740 | 140 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $1,034 | 153 | Shares | Sole | 2025-02-21 | |
| No filing history on record for this holder in this stock. | ||||||